Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)

NCT02014363 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: ETS6103 (low dose)
DRUG: ETS6103 (high dose)
DRUG: Amitriptyline

Sponsor

e-Therapeutics PLC